Related Experiment Video

Updated: May 30, 2026

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on: July 17, 2020

Recent patents related to phosphorylation signaling pathway on cancer

Karina B Acosta1, María M Tibolla, María M Tiscornia

  • 1Laboratory of Molecular Biotechnology – Facultad de Ciencias Exactas Químicas y Naturales - Universidad Nacional de Misiones.

Recent Patents on DNA & Gene Sequences
|August 11, 2011
PubMed

Insights

Phosphorylation regulates cell growth and survival. Key signaling molecules like EGFR and PI3K influence cancer development by controlling NF-κB activity, leading to new therapeutic strategies.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Cancer Research

Background:

  • Phosphorylation and dephosphorylation are crucial for regulating cell signaling pathways.
  • Growth factor and cytokine signaling impact cell proliferation, differentiation, survival, and apoptosis.
  • Aberrant signaling pathways are implicated in carcinogenesis.

Purpose of the Study:

  • To explore the role of specific signaling molecules in cancer development.
  • To review current patented therapeutic strategies targeting these pathways.
  • To highlight the need for deeper understanding of molecular mechanisms for novel cancer therapies.

Main Methods:

  • Review of scientific literature and patent analysis.
  • Focus on signaling pathways involving EGFR, somatostatin receptors, SHP-1, Akt, and PI3K.
  • Analysis of NF-κB regulation in cancer.

Main Results:

  • EGFR, somatostatin receptors, SHP-1, Akt, and PI3K signaling can influence carcinogenesis via NF-κB.
  • Patents focus on diagnosis, prognosis, and treatment of cancers involving these pathways.
  • Current therapeutic approaches include inhibition and antagonism.

Conclusions:

  • Understanding these signaling pathways is vital for cancer therapy.
  • Development of alternative therapies beyond inhibitors is necessary.
  • Further research into molecular mechanisms can lead to novel treatment strategies.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...